LIMNW vs ROK
Liminatus Pharma, Inc. Warrants (LIMNW) versus Rockwell Automation Inc (ROK) — a side-by-side from cached financials, not a winner call.
Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on US.
Rockwell Automation Inc (ROK) is a specialty industrial machinery company listed on NYSE.
LIMNW does not have a complete income-statement cache yet.
Latest reported ROK revenue for 2025-09-30 was $8.34B. Net income was $749.0M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
LIMNW currently screens at market cap $0. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
Not investment advice. Open the LIMNW and ROK stock pages for the full models.
Not investment advice.